HHS Contracts Aim To Fund Adjuvant Vaccines Research
GSK, Novartis and Iomai are awarded multi-million dollar contracts to fund adjuvant-based pandemic influenza vaccine development.
GSK, Novartis and Iomai are awarded multi-million dollar contracts to fund adjuvant-based pandemic influenza vaccine development.